Shanghai Fosun Pharmaceutical (group) Co., Ltd. - Net Worth and Insider Trading

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shanghai Fosun Pharmaceutical (group) Co., Ltd. owns 2 companies in total, including Natures Sunshine Products Inc (NATR) , and ContraFect Corp (CFRXQ) .

Click here to see the complete history of Shanghai Fosun Pharmaceutical (group) Co., Ltd.’s form 4 insider trades.

Insider Ownership Summary of Shanghai Fosun Pharmaceutical (group) Co., Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
NATR	Natures Sunshine Products Inc	2019-12-11	10 percent owner
CFRXQ	ContraFect Corp	2017-07-25	10 percent owner

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Ownership Network

Ownership Network List of Shanghai Fosun Pharmaceutical (group) Co., Ltd.

No Data

Ownership Network Relation of Shanghai Fosun Pharmaceutical (group) Co., Ltd.

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Owned Company Details

What does Natures Sunshine Products Inc do?

Who are the key executives at Natures Sunshine Products Inc?

Shanghai Fosun Pharmaceutical (group) Co., Ltd. is the 10 percent owner of Natures Sunshine Products Inc. Other key executives at Natures Sunshine Products Inc include EVP & President & Asia Daniel C Norman , EVP & General Counsel Nathan G Brower , and Global Chief Marketing Officer Sarah Crockett .

Natures Sunshine Products Inc (NATR) Insider Trades Summary

Over the past 18 months, Shanghai Fosun Pharmaceutical (group) Co., Ltd. made no insider transaction in Natures Sunshine Products Inc (NATR). Other recent insider transactions involving Natures Sunshine Products Inc (NATR) include a net sale of 42,706 shares made by Daniel C Norman , a net sale of 20,367 shares made by Nathan G Brower , and a net sale of 24,468 shares made by Bryant J Yates .

In summary, during the past 3 months, insiders sold 0 shares of Natures Sunshine Products Inc (NATR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 87,541 shares of Natures Sunshine Products Inc (NATR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 87,541 shares.

Natures Sunshine Products Inc (NATR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Natures Sunshine Products Inc Insider Transactions

No Available Data

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Shanghai Fosun Pharmaceutical (group) Co., Ltd.. You might contact Shanghai Fosun Pharmaceutical (group) Co., Ltd. via mailing address: Building A, No. 1289 Yishan Road, Shanghai F4 200233.

Discussions on Shanghai Fosun Pharmaceutical (group) Co., Ltd.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.